Skip to content

Recommendation for cardiac rehabilitation following myocardial infarction - a multicenter retrospective study to identify influencing clinical and patient-related characteristics

Recommendation for cardiac rehabilitation following myocardial infarction - a multicenter retrospective study to identify influencing clinical and patient-related characteristics - Rehab-Support

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031861
Enrollment
12000
Registered
2023-06-27
Start date
2024-02-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I21 I22

Interventions

Group 1: A retrospective analysis of secundary data of myocardial infarction patients will focus on variables influencing "recommendation for cardiac rehabilitation" We will analyse secondary data fr

Sponsors

Universitätsklinikum Essen - Institut für Medizinische Informatik, Biometrie und Epidemiologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: inpatient patients with ICD I I21.- und I22.-

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
The primary endpoint is "Recommendation for follow-up rehabilitation after myocardial infarction confirmed" (nominal variable). We will analyse secondary data from 2017 to 2022 using a stratified sample of MI-patients. Because this is a retrospective study with secondary data, there is no intervention, so information on follow-up or survey instruments is omitted.

Secondary

MeasureTime frame
As a secondary endpoint, we will evaluate "other medical referral" such as "further treatment by family physicians".

Countries

Germany

Contacts

Public ContactClaudia Pieper

Universitätsklinikum Essen AöR

claudia.pieper@uk-essen.de+4920172377239

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026